SUMITOMO CHEMICAL INDIA LIMITED
₹315.70-₹16.25 (-4.9%)
Last close · Data as of Oct 30, 2026
- Market cap
- ₹22,020 Cr
- P/E
- 40.7x
- EV / EBITDA
- 37.9x
- Revenue
- ₹3,090 Cr
- Net margin
- 13.1%
- ROCE
- 19.2%
Price chart
Technical chartScreen technicals →-37.9% over the last year
Daily closes.
Go deeper
Technical chart: candles, 9 moving averages, RSI, MACD and drawing tools
Performance
Price change over each period, before dividends.
- 1M
- -27.2%
- 3M
- -38.0%
- 6M
- -24.7%
- 1Y
- -37.9%
- 5Y
- -19.0%
52-week range
Day change -₹16.25 (-4.9%) from ₹332 to ₹316 · Last close Oct 30, 2026
Best weekday to invest, historically
The same weekly amount in SUMICHEM, bought on each weekday since 2021.
AI Summary
Indian StockStrengths1
- Healthy return on equity of 15.2%
Concerns1
- Slow revenue growth of 3.2% CAGR over 5 years
Rule-based from financial data. Not advice.
About the company
Sumitomo Chemical India Limited engages in the manufacture and sale of household and public health insecticides, agricultural pesticides, and animal nutrition products in India and internationally. It also offers crop protection products, such as insecticides, herbicides, fungicides, and miticides; animal nutrition; plant nutrition and plant growth regulators; fumigants and rodenticides; weedicides; and biological products. The company was incorporated in 2000 and is headquartered in Mumbai, India. Sumitomo Chemical India Limited is a subsidiary of Sumitomo Chemical Company Limited.
- Sector
- Materials
- Shares outstanding
- 49.8 Cr shares
- ISIN
- INE258G01013
- BSE code
- 542920
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- ₹22,020 Cr
- P/E
- 40.7x
- P/B
- 6.9x
- EV / EBITDA
- 37.9x
- EV / Sales
- 7.6x
- P/S
- 7.8x
- Earnings yield
- 2.5%
- 52-week high
- ₹564.65
- 52-week low
- ₹315.70
Profitability
- Operating margin
- 16.7%
- Net margin
- 13.1%
- EBITDA margin
- 20.1%
- ROE
- 15.2%
- ROCE
- 19.2%
- ROA
- 11.3%
- Dividend payout
- 80.0%
- Tax rate
- 27.0%
- Other income, % of PBT
- 19.1%
Growth
- RevenueLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹3,090 Cr
- Revenue growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 9.1%
- Revenue CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 3.2%
- EBITDALatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹570 Cr
- EBITDA growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -20.1%
- Net profit growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 35.7%
- Net profit CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 12.4%
- Cash from operationsLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹756 Cr
- CFO growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 94.3%
- Free cash flowLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -₹11.0 Cr
- Asset growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -2.4%
Solvency and efficiency
- Current ratio
- 3.38
- Debt / Equity
- 0.01
- Debt / Assets
- 0.01
- Debt / EBITDA
- 0.04
- Interest coverage
- 94.80
- Financial leverage
- 1.35
- CFO / Net profit
- 2.04
- Cash / Market cap
- 10.7%
- Cash per share
- ₹47.19
- Asset turnover
- 0.86
- Fixed asset turnover
- 5.79
- Capital intensity
- 0.17
- Debtor days
- 91 days
- Inventory turnover
- 2.70
- Cash conversion cycle
- 131 days
Where the revenue went
Of every ₹100 of FY2025 revenue, ₹16 was left as net profit.
| From | To | Amount |
|---|---|---|
| Sales | Expenses | ₹2,467 Cr |
| Sales | Operating profit | ₹623 Cr |
| Operating profit | Interest | ₹6 Cr |
| Operating profit | Depreciation | ₹63 Cr |
| Operating profit | Profit before tax | ₹554 Cr |
| Other income | Profit before tax | ₹119 Cr |
| Profit before tax | Tax and other | ₹172 Cr |
| Profit before tax | Net profit | ₹502 Cr |
Revenue and net profit
Revenue grew 9.1% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2021 | ₹2,643 Cr | ₹345 Cr |
| FY2022 | ₹3,060 Cr | ₹434 Cr |
| FY2023 | ₹3,511 Cr | ₹503 Cr |
| FY2024 | ₹2,833 Cr | ₹370 Cr |
| FY2025 | ₹3,090 Cr | ₹502 Cr |
Cash flows
FY2025: ₹459 Cr from operations, ₹55.0 Cr free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2021 | ₹424 Cr | ₹142 Cr |
| FY2022 | ₹223 Cr | -₹58 Cr |
| FY2023 | ₹389 Cr | ₹62 Cr |
| FY2024 | ₹756 Cr | ₹330 Cr |
| FY2025 | ₹459 Cr | ₹55 Cr |
Growth
Latest fiscal year FY2025 (ending March): each figure with its change over the year before.
- Revenue
- ₹3,090 Cr+9.1%1Y
- Net profit
- ₹502 Cr+35.7%1Y
- Cash from operations
- ₹459 Cr
- Free cash flow
- ₹55 Cr-83.3%1Y
- Revenue CAGR, 5Y
- 3.2%
- EBITDA CAGR, 5Y
- 12.6%
- Net profit CAGR, 5Y
- 12.4%
| Year | Revenue | Operating income | EBITDA | Net profit | CFO | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹3,090 Cr | ₹623 Cr | — | ₹502 Cr | ₹459 Cr | ₹55 Cr | 17.3% | +9.1% | +35.7% |
Monthly returns
Month-by-month returns of SUMICHEM across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Liabilities and equity | ₹3,930 Cr |
| Equity capital | ₹499 Cr |
| Reserves | ₹2,397 Cr |
| Borrowings | ₹45 Cr |
| Other liabilities | ₹988 Cr |
| Assets | ₹3,930 Cr |
| Fixed assets | ₹482 Cr |
| Capital work in progress | ₹28 Cr |
| Investments | ₹601 Cr |
| Other assets | ₹2,819 Cr |
Market cap against peers
8 peers: same sector group, nearest by size.
P/E against peers
SUMICHEM trades at 40.7x earnings against a peer median of 35.5x (a 15% premium).
Not shown (no positive earnings and no EV / Sales): KIOCL Limited.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| SUMITOMO CHEMICAL INDIA LIMITEDSUMICHEMthis companyP/E ↑ premium | ₹22,020 Cr | 40.7x | 6.9x | 15.2% | 37.9x |
| The Ramco Cements LimitedRAMCOCEM | ₹25,613 Cr | 133.0x | 3.4x | 5.5% | 18.8x |
| Himadri Speciality Chemical Ltd.HSCL | ₹23,955 Cr | 35.8x | 5.9x | 13.8% | 35.2x |
| Shyam Metalics and Energy LimitedSHYAMMETL | ₹22,691 Cr | 43.5x | 3.7x | 6.3% | 30.4x |
| KIOCL LimitedKIOCL | ₹22,004 Cr | — | 13.3x | -4.3% | -995.6x |
| Deepak Nitrite LimitedDEEPAKNTR | ₹21,434 Cr | 101.0x | 6.8x | 14.7% | 32.6x |
| Bayer CropScience Limited.BAYERCROP | ₹19,912 Cr | 32.7x | 6.4x | 26.0% | 18.5x |
| Kansai Nerolac PaintsKANSAINER | ₹18,778 Cr | 28.4x | 2.9x | 20.9% | 10.4x |
| Gujarat Mineral Development CorporaGMDCLTD | ₹18,131 Cr | 27.5x | 2.7x | 9.8% | 19.5x |
| Peer median | — | 35.5x | 3.7x | 12.9% | 19.2x |
Year-to-date ROI
SUMICHEM since 1 January, against earlier years.
Historical volatility
SUMICHEM's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, in ₹ crore, grouped into plain-language lines.
Figures in ₹ crore as reported, fiscal years ending March, newest first; the trailing twelve months (TTM) last.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2021 | 18.0% |
| FY2022 | 20.0% |
| FY2023 | 19.0% |
| FY2024 | 17.0% |
| FY2025 | 20.0% |
| Line | FY2025 |
|---|---|
| RevenueSales | ₹3,090 Cr |
| Costs | |
| Interest | ₹6 Cr |
| Expenses | ₹2,467 Cr |
| Operating profitOperating Profit | ₹623 Cr |
| Other income and charges | |
| Profit before tax | ₹674 Cr |
| Tax | |
| Net profitNet Profit | ₹502 Cr |
| Per share |
| Line | FY2025 |
|---|---|
| Liabilities and equityTotal Liabilities | ₹3,930 Cr |
| Equity capitalEquity Capital | ₹499 Cr |
| Reserves | ₹2,397 Cr |
| Borrowings | ₹45 Cr |
| Other liabilitiesOther Liabilities | ₹988 Cr |
| AssetsTotal Assets | ₹3,930 Cr |
| Fixed assetsFixed Assets | ₹482 Cr |
| Capital work in progressCWIP | ₹28 Cr |
| Investments | ₹601 Cr |
| Other assetsOther Assets | ₹2,819 Cr |
| Line | FY2025 |
|---|---|
| Operating cash flowCash from Operating Activity | ₹459 Cr |
| Investing cash flowCash from Investing Activity | -₹404 Cr |
| Financing cash flowCash from Financing Activity | -₹66 Cr |
| Change in cashNet Cash Flow | -₹11 Cr |
Learn while you research
Academy chapters picked for SUMITOMO CHEMICAL INDIA LIMITED and the metrics on this page.
- 01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read
- 02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 03 Valuation Multiples ExplainedThis stock trades at a P/E of 40.7, learn when high multiples are justified.6 min read
- 04 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 05 Business Cycles & StocksThese cyclical sectors win and lose in different macro phases.6 min read
- 06 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read